PositiveID's New President Lyle L. Probst Interviewed by SmallCapVoice.com About Company's Latest Contract
April 29 2014 - 8:00AM
SmallCapVoice.com, Inc. announced today that a new audio interview
with PositiveID Corporation ("PositiveID" or the "Company")
(OTCQB:PSID), a developer of biological detection and diagnostics
solutions, is now available. The interview can be heard at
http://smallcapvoice.com/blog/4-25-14-smallcapvoice-interview-with-positiveid-corporation-psid.
PositiveID's new President, Lyle L. Probst, called in to
SmallCapVoice.com to discuss the Company's recently announced news
related to a U.S. Defense Threat Reduction Agency ("DTRA") contract
to conduct research and development to combat weapons of mass
destruction. Mr. Probst also provided his personal insights
regarding how PositiveID fits into the biological detection and
diagnostics industry and much more.
SmallCapVoice.com is a recognized corporate investor relations
firm, with clients nationwide, known for its ability to help
emerging growth companies build a following among retail and
institutional investors. SmallCapVoice.com utilizes its stock
newsletter to feature its daily stock picks, audio interviews, as
well as its clients' financial news releases. SmallCapVoice.com
also offers individual investors all the tools they need to make
informed decisions about the stocks they are interested in. Tools
like stock charts, stock alerts, and Company Information Sheets can
assist with investing in stocks that are traded on the OTC BB and
Pink Sheets. To learn more about SmallCapVoice.com and their
services, please visit
http://www.smallcapvoice.com/services.html.
About PositiveID Corporation
PositiveID Corporation is an emerging growth company and
developer of biological detection systems for America's homeland
defense industry as well as rapid biological testing. PositiveID is
focused on the development of microfluidic systems for the
automated preparation of and performance of biological assays in
order to detect biological threats and analyze biological samples.
For more information on PositiveID, please visit
http://www.PositiveIDCorp.com.
Statements about PositiveID's future expectations constitute
"forward-looking statements" within the meaning of Section 27A of
the Securities Act of 1933, Section 21E of the Securities Exchange
Act of 1934, and as that term is defined in the Private Litigation
Reform Act of 1995. Such forward-looking statements involve risks
and uncertainties and are subject to change at any time, and
PositiveID's actual results could differ materially from expected
results. Additional information about these and other factors that
could affect the Company's business is set forth in the Company's
various filings with the Securities and Exchange Commission,
including those set forth in the Company's 10-K filed on April 11,
2014, and 10-Qs filed on May 20, 2013, August 14, 2013, as amended
August 19, 2013, and November 19, 2013, under the caption "Risk
Factors." The Company undertakes no obligation to update or release
any revisions to these forward-looking statements to reflect events
or circumstances after the date of this statement or to reflect the
occurrence of unanticipated events, except as required by law.
CONTACTS: PositiveID Corporation
Allison Tomek
561-805-8000
atomek@positiveidcorp.com
Contact for SmallCapVoice.com:
Stuart T. Smith
512-267-2430
info@smallcapvoice.com